Chemotherapy following radiation treatment slows disease progress
(Mayo Clinic) A chemotherapy regimen consisting of procarbazine, CCNU, and vincristine administered following radiation therapy improved progression-free survival and overall survival in adults with low-grade gliomas, a form of brain cancer, when compared to radiation therapy alone. The findings were part of the results of a Phase III clinical trial presented today at the Society for Neuro-Oncology's 19th Annual Meeting in Miami by the study's primary author Jan Buckner, M.D., deputy director, practice, at Mayo Clinic Cancer Center.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Glioma | Health | International Medicine & Public Health | Neurology | Radiation Therapy | Study